↓ Skip to main content

Pharmacotherapies for cannabis dependence

Overview of attention for article published in Cochrane database of systematic reviews, December 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
policy
3 policy sources
twitter
10 X users
facebook
2 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
105 Dimensions

Readers on

mendeley
241 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pharmacotherapies for cannabis dependence
Published in
Cochrane database of systematic reviews, December 2014
DOI 10.1002/14651858.cd008940.pub2
Pubmed ID
Authors

Kushani Marshall, Linda Gowing, Robert Ali, Bernard Le Foll

Abstract

Cannabis is the most prevalent illicit drug in the world. Demand for treatment of cannabis use disorders is increasing. There are currently no pharmacotherapies approved for treatment of cannabis use disorders.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Brazil 1 <1%
Unknown 239 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 37 15%
Student > Ph. D. Student 35 15%
Researcher 33 14%
Student > Bachelor 27 11%
Student > Postgraduate 20 8%
Other 51 21%
Unknown 38 16%
Readers by discipline Count As %
Medicine and Dentistry 82 34%
Psychology 36 15%
Nursing and Health Professions 20 8%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Neuroscience 11 5%
Other 29 12%
Unknown 51 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2022.
All research outputs
#953,822
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#1,878
of 11,842 outputs
Outputs of similar age
#11,584
of 348,020 outputs
Outputs of similar age from Cochrane database of systematic reviews
#42
of 267 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,020 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 267 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.